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Abstract
Purpose The purpose of this study was to find out the most
important prognostic factors for achieving a pregnancy after
in vitro fertilization (IVF) in women with history of repeated
unsuccessful IVF attempts.
Methods We analyzed factors affecting pregnancy rate in a
retrospective study including 429 IVF/ICSI cycles performed
in women younger than 40 years with at least three previous
consecutive failed IVF/ICSI attempts.
Results Clinical pregnancy was observed in 140/429 (32.6%)
cycles. Clinical pregnancy rate (CPR) was significantly higher
in cycles with LEI compared to cycles without LEI before
embryo transfer (44.4 vs 26.54%, p = 0.007). The CPR was
also higher in cycles with day 5 blastocyst- compared with day
3 cleavage-stage embryo transfers (45.51 vs 26.54%,
p < 0.001). In multivariate logistic regressionmodel, only trans-
fer of at least one good quality embryo (OR = 4.32, 95% CI
2.41–7.73), local endometrial injury (OR = 1.73, 95% CI 1.02–
2.92), and transfer on day 5 (OR = 3.02, 95% CI 1.53–5.94)
remained important independent prognostic factors for clinical
pregnancy.
Conclusions These results suggest that hysteroscopy with lo-
cal injury to the endometrium prior to ovarian stimulation for
IVF/ICSI can improve implantation and pregnancy rates in
women experiencing recurrent IVF failure. However, large
studies are needed to confirm these findings.
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Introduction
Repeated IVF treatment failure is very frustrating to the pa-
tients as well as to the clinicians. Even in subsequent IVF/ICSI
cycles, lower pregnancy rates can be expected in these patients
[1, 2]. Many research efforts have been invested to find the
factors that affect the pregnancy rate in these couples, not only
to advise patients about treatment success but also to propose
methods of treatment that would improve their possibility of
conception. The woman’s age, the indication for IVF, ovarian
reserve, the treatment protocol employed, uterine pathology,
immunological factors, number of embryos transferred, num-
ber of available embryos, embryo quality, embryo transfer
technique, sperm quality, and luteal phase support were iden-
tified as interfering with successful implantation and contrib-
uting to recurrent failure. However, reduced endometrium re-
ceptivity and low embryo quality are thought to be the most
important factors [3].
Several approaches have been proposed to improve success
rates in these women, including blastocyst culture, local en-
dometrial injury (LEI), assisted hatching, sequential transfer,
co-culture system, zygote intrafallopian transfer, pre-
implantation genetic screening (PGS), intracytoplasmic mor-
phologically selected sperm injection (IMSI) for treating male
infertility, etc. However, the benefit of these methods has not
been confirmed in properly designed studies. LEI and blasto-
cyst transfer are the methods with most evidence in the
literature.
A LEI in the luteal phase of the cycle preceding ovarian
stimulation for IVF has been associated with improved implan-
tation in womenwith unexplained repeated implantation failure
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(RIF). Systematic review of the literature and meta-analysis of
seven studies published until 2012 showed that pregnancy rate
in women who have undergone LEI was 71% higher compared
to pregnancy rate in women with no intervention. (RR 1.71,
95% CI 1.44–2.02) [4]. In a subsequent Cochrane review
which included 14 studies, LEI was also associated with higher
pregnancy rate, but the benefit of this procedure was less evi-
dent (RR 1.34, 95% CI 1.21–1.61) and the authors concluded
that more evidence fromwell-designed trials is needed [5]. The
possible bias is also that there is no uniform definition of RIF.
Not all follow the recommendation that RIF is not the same as
repeated IVF treatment failure and that the definition of RIF
requires good-quality embryos to be transferred [6, 7]. The
effect of LEI still remains controversial and the subgroup of
patients with RIF who would mostly benefit from LEI still
needs to be identified. Despite these concerns it was found in
recent survey that in women with RIF, 92% of clinicians would
recommend LEI [8].
In patients with repeated IVF treatment failure, blastocyst
transfer is also often advised. This recommendation are based
on studies that have found higher implantation rate for women
who underwent blastocyst transfer compared to those in
whom embryos were transferred on day 2 or day 3 [9–12].
But in some others, no beneficial effect of blastocyst transfer
was reported [2, 13].
Despite that, there is some evidence to support both men-
tioned approaches; LEI and blastocyst transfer together with
other prognostic factors affecting pregnancy rate have not yet
been studied using multiple logistic regression model in unse-
lected group of women with repeated IVF failure.
Materials and methods
We included 429 IVF/ICSI cycles performed in women youn-
ger than 40 years with at least three previous consecutive
failed IVF/ICSI attempts in a retrospective study. The data
were retrieved from the database of all IVF/ICSI cycles con-
ducted at the Department for Reproductive Medicine,
University Medical Centre, Maribor, Slovenia, from January
2014 to December 2015. Cycles in women with uterine pa-
thology, with intrauterine procedures in the last 3 months, with
poor ovarian response according to the Bologna criteria, and
those without embryo transfer were excluded. According to
the doctor-patient agreement some women were scheduled for
LEI. In all women, LEI was performed in the luteal phase of
the cycle preceding ovarian stimulation in an office hysteros-
copy setting. Multiple endometrial injuries approximately
2 mm in depth and width in the upper part of the uterine cavity
were performed using grasping forceps or scissors.
Patients underwent ovarian stimulation using protocols with
combination of GnRH agonist/GnRH antagonist and recombi-
nant FSH (Gonal-F, Serono International SA, Geneva,
Switzerland)/HMG (Menopur, Ferring Pharmaceuticals Inc.,
Saint-Prex, Switzerland) that were previously described in de-
tail [14]. After oocyte fertilization using IVF or ICSI procedure,
embryos were cultured in the BlastAssist extended culture me-
dia (Origio, Denmark). Embryo quality was assessed by an
experienced embryologist at day 2 and 3 after oocyte fertiliza-
tion. Day 5 blastocyst transfer was performed if more than three
optimal embryos were available on day 3 according to our
standard policies. After consultation with the patients, time of
embryo transfer was adjusted to day 3 or day 5 according to
doctor-patient agreement. Blastocysts were graded according to
our established grading system 5 days after oocyte fertilization
[15, 16]. In brief, the blastocyst was considered optimal if it was
fully expanded and the blastocoel completely filled the embryo.
It contained a cohesive trophectoderm and a compact inner cell
mass (ICM). No more than three embryos on day 3 and no
more than two embryos on day 5 were transferred. Surplus
blastocysts, not selected for transfer were cryopreserved. After
embryo transfer, patients received luteal-phase support with
600 mg of vaginal progesterone daily (Utrogestan, Ferring
Pharmaceuticals Inc., Saint-Prex, Switzerland). Serum hCG
level wasmeasured 16 days after oocyte pick-up and ultrasound
was performed 2 weeks later if the blood test confirmed the
pregnancy. Clinical pregnancy was defined as the presence of
a gestational sac with a fetal heartbeat.
Patients’ and cycles’ characteristics were compared be-
tween the conception and non-conception cycles. Statistical
analysis was performed with Statistica 8.0 data software sys-
tem analysis (Stat Soft Inc., Tulsa, OK, USA). The normal
distribution of numeric variables was determined by the
Shapiro-Wilk test. Student’s t test or the Mann-WhitneyU test
was used to assess these variables, depending on the data
distribution. Mean and standard deviation for each continuous
variable were calculated. Cross-tables and chi-square analysis
were employed in the evaluation of the categorical data. The
association between patients’/cycles’ characteristics and clin-
ical pregnancy were also analyzed with univariate logistic
regression. Variables proven statistically significant by univar-
iate logistic analysis were tested with multiple logistic regres-
sion model. Odds ratios and their 95% confidence intervals
(CIs) were calculated. p value < 0.05 was considered statisti-
cally significant.
Results
Among 429 included cycles, clinical pregnancy was observed
in 140 (32.6%) of them. LEI were performed in 90 (23.3%)
cycles preceding embryo transfer. The clinical pregnancy rate
(CPR) in this subgroup was significantly higher compared
with CPR in cycles without LEI (44.4 vs 26.54%,
p = 0.007). CPR was higher after LEI in cycles with day 5
embryo transfer (54.8 vs 37.12%) as well as in cycles with day
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3 embryo transfer (35.4 vs 25.7%). Embryo transfer on day 5
was done in 155 (36.1%) cycles and resulted in 71 clinical
pregnancies. The CPR was higher in cycles with day 5 com-
pared with CPR in cycles with day 3 embryo transfer (45.51
vs 26.54%, p < 0.001). Embryo transfer of at least one good
quality embryowas performed in 271 (63.17%) cycles achiev-
ing significantly higher CPR than after transfer of lower qual-
ity embryos (39.48 vs 20.88%, p < 0.001). There were no
statistically significant differences between conception and
non-conception cycles in women’s age, number of previous
IVF cycles, causes of infertility and number of transferred
embryos. Statistically significant different total dose of gonad-
otrophins, number of oocytes retrieved, number of embryos,
number of good quality embryos on day two, number of blas-
tocysts, number of freezing blastocysts, proportion of cycles
with embryo freezing, proportion of cycles with embryo trans-
fer of at least one good quality embryo, proportion of cycles
with day five ET and proportion of cycles with LEI were
observed in conception compared to non-conception cycles
(Table 1).
These parameters were also found to be associated with
clinical pregnancy using univariate logistic regression. In mul-
tivariate logistic regression model, only transfer of at least one
good-quality embryo, local endometrial injury and transfer on
day 5 remained important independent prognostic factors for
clinical pregnancy (Table 2).
We have also performed the multivariate regression analy-
sis including only the two significant variables at the same
time. By using this approach, these three variables remained
independent prognostic factors for clinical pregnancy in each
of the models.
Discussion
We have shown that local endometrial injury and blastocyst
transfer are important independent prognostic factors for
achieving a clinical pregnancy after previous recurrent failed
IVF. In our study, we have conducted a multivariable analysis
in order to account for all important factors that could affect
the pregnancy rate together in the current cycle. Poor ovarian
response according to the Bologna criteria and advanced age
are very well-documented and common causes of recurrent
IVF failure, and these cycles were excluded from study. We
only included cycles with embryo transfer, so that a relatively
high clinical pregnancy rate of 32.6% is not unexpected.
In conception cycles compared to non-conception cycles,
higher number of oocytes retrieved, all available embryos,
good-quality embryos, blastocysts, freezing surplus blasto-
cysts, proportion of cycles with embryo transfer of at least
one good-quality embryo, and lower dose of gonadotrophins
were all related to a higher clinical pregnancy rate which is in
consistence with findings of other authors [3, 15–18]. Women
who did not get pregnant were older that those who did, but
this difference did not reach statistical significance. The main
reason could be the fact that the pregnancy rate after IVF
decreased with increasing age, but decline is most pronounced
after 40 years, and this group of women was excluded from
our study. According to our findings, the number of trans-
ferred embryos is not an important factor affecting pregnancy
rate. In most cycles, two embryos were transferred, and as it
was demonstrated in a recent systematic review, transferring
more than two embryos is not associated with a higher birth
rate [19].
Table 1 Patients’ and cycles’
characteristics Conception IVF
cycles N = 140
Non-conception IVF
cycles N = 289
p value
Age (years) 33.82 ± 3.41 34.52 ± 3.07 NS
No. of previous cycles 4.30 ± 1.44 4.75 ± 2.23 NS
Male factor infertility (N, %) 68 (48.57) 138 (47.75) NS
Total gonadotrophin dose (X 75 IU) 28.82 ± 10.21 31.21 ± 11.68 0.02
No. of oocytes retrieved 11.61 ± 5.19 9.93 ± 5.79 <0.001
ICSI (N, %) 93 (66.42) 200 (69.20) NS
No. of embryos on day 2 6.95 ± 3.78 5.34 ± 3.52 <0.001
No. of good-quality embryos (day2) 4.63 ± 3.63 3.35 ± 3.12 <0.001
No. of blastocysts 2.76 ± 2.90 1.47 ± 2.46 <0.001
Day 5 embryo transfer (%) 71 (50.71) 84 (30.43) <0.001
Number of embryos transferred 1.89 ± 0.49 1.79 ± 0.65 NS
ET of at least one quality embryo (N, %) 107 (76.43) 164 (56.75) <0,001
Cycles with embryo cryopreservation (N, %) 69 (49.29) 195 (32.53) <0.001
Number of embryos cryopreserved 1.46 ± 2.13 0,80 ± 1.71 <0.001
Local endometrial injury (N, %) 40 (28.57) 50 (17.30) 0.01
ICSI intracytoplasmic sperm injection, ET embryo transfer, NS not significant
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Blastocyst transfer was an independent prognostic factor
for clinical pregnancy in our study (OR = 3.02 (1.53–5.94)).
The possible benefit of blastocyst transfer is better embryo
selection and synchronization of embryo stage with the endo-
metrium [20]. In our study, we calculated pregnancy rate per
transfer instead of per cycle. Considering this aspect, better
embryo selection may be an even more important aspect of
blastocyst transfer in our group of patients. Another reason for
this assumption is also our transfer policy, which means that
day 5 transfer is performed only if more than three optimal
embryos were available on day 3. Nonetheless, multiple lo-
gistic regression model demonstrated that day 5 is an indepen-
dent prognostic factor for pregnancy, irrespectively, to the
number and quality of embryos on day 2. However, from
the results of this study, it is impossible to assert that the same
embryo has a better chance to implant if it is transferred on day
5 instead of day 3. In our previous study where pregnancy rate
per cycle was compared between day 2 and day 5 transfer in
cycles with one or two developed embryos, no differences
were found [21, 22], but those studies included unselected
group of women and not only patients with repeated IVF
treatment failure.
Several studies have shown that local endometrial injury
(LEI) can improve implantation rates in patients with unex-
plained repeated implantation failure. Still, there is a lot of
debate on this subject due to heterogeneity in the design of
the studies. Despite the lack of uniformity of the definition,
relatively recent suggested consensus which is most com-
monly applied today is that RIF should be defined as a
failure of implantation in at least three consecutive IVF at-
tempts in which 1–2 embryos of high-grade quality are
transferred in each cycle [6, 23]. Our study confirmed the
positive effect of LEI in patients with recurrent IVF failure,
since pregnancy rate in women who have undergone hyster-
oscopy and LEI was 73% higher compared to pregnancy
rate in women with no intervention (OR 1.73, 95% CI
1.02–2.92). The local injury to the endometrium can be in-
duced by endometrial biopsy (scratch) or hysteroscopy, and
it has been shown that endometrial biopsy is twice as effec-
tive as opposed to hysteroscopy [4]. In our study, women
underwent hysteroscopy not only to perform endometrial
biopsy under visual control, but also to exclude pathology
of uterine cavity, which can also contribute to improving the
chances of conception. LEI was performed according to
doctor-patient agreement, meaning that not every patient
with recurrent IVF failure underwent this procedure and
LEI was also done in patients who do not completely fulfill
the recommended criteria for RIF [6, 23], regarding high-
grade embryo quality.
A limitation of the study is that LEI was performed in a
relatively low proportion of patients with previous unsuccess-
ful IVF attempts. Due to the retrospective nature of the study
and non-specific criteria for LEI, there is a possibility of a
selection bias. Nonetheless, we used a multiple regression
model in order to account for possible confounders and to
overcome this methodological problem. Limitation of our
study is also that not all factors that could interfere with im-
plantation were included in analysis.
Our results suggest that quality of transferred embryos is
the most important prognostic factor for conception and that
blastocyst transfer and LEI should be recommended to pa-
tients with repeated IVF failure in order to improve the preg-
nancy rate. Larger prospective multi-center studies are needed
to confirm these findings.
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Table 2 Univariate and
multivariate logistic regression
analysis assessing predictors of
clinical pregnancy after in-vitro-
fertilization (IVF) in women with
history of at least three
consecutive unsuccessful IVF
attempts (coefficient = −2.31,
final loss: 237.45, chi2
(10) = 63.16, p < 0.001)
Independent variable Univariate regression Multivariate regression
Odds ratio (95% CI) p value Odds ratio (95% CI) p value
Total gonadotrophin dose 0.26 (0.06–0.94) 0.04 0.99 (0.97–1.01) 0.31
Number of oocytes retrieved 4.67 (1.61–13.50) 0.004 0.98 (0.93–1.04) 0.61
Number of embryos on day 2 14.68 (4.06–53.05) >0.001 1.12 (0.99–1.28) 0.07
Number of good-quality embryos (day2) 12.67 (3.44–46.57) >0.001 0.95 (0.83–1.09) 0.46
Number of blastocysts 16.46 (4.81–56.32) >0.001 1.09 (0.90–1.33) 0.35
ET of at least one good quality embryo 2.47 (1.56–3.89) >0.001 4.32 (2.41–7.73) <0.001
Cycles with embryo cryopreservation 2.02 (1.33–3.05) >0.001 1.05 (0.55–1.99) 0.89
Number of cryopreserved embryos 15.11(2.93–77.71) 0.001 0.84 (0.65–1.09) 0.19
Local endometrial injury 1.91 (1.18–3.08) 0.008 1.73 (1.02–2.92) 0.040
Day 5 embryo transfer 2.51 (1.65–3.81) >0.001 3.02 (1.53–5.94) 0.001
ET embryo transfer, CI confidence interval
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